SEC Form 4 · accession 0000884731-16-000077
ARIAD PHARMACEUTICALS INC · ARIA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Athanese Lavidas
Director
Period of report
Jun 13, 2016
Accepted (ET)
Jun 15, 2016 · 4:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884731
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 13, 2016 | M | 10,000 | $5.49 | A | 141,631 | D | |
| Common StockF2 | Jun 13, 2016 | S | 10,000 | $8.205 | D | 131,631 | D | |
| Common Stock | Jun 14, 2016 | M | 10,000 | $5.49 | A | 141,631 | D | |
| Common Stock | Jun 14, 2016 | M | 10,000 | $7.39 | A | 151,631 | D | |
| Common StockF3 | Jun 14, 2016 | S | 20,000 | $8.1426 | D | 131,631 | D | |
| Common Stock | Jun 15, 2016 | M | 15,000 | $7.39 | A | 146,631 | D | |
| Common Stock | Jun 15, 2016 | M | 25,000 | $6.45 | A | 171,631 | D | |
| Common Stock | Jun 15, 2016 | M | 6,250 | $4.91 | A | 177,881 | D | |
| Common StockF4 | Jun 15, 2016 | S | 46,250 | $8.2408 | D | 131,631 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F5,F6 | $5.49 | Jun 13, 2016 | M | 10,000 | D | Jun 28, 2008 | Jun 28, 2017 | Common Stock | 10,000 | 10,000 | D |
| Stock Option (Right to Buy)F5,F6 | $5.49 | Jun 14, 2016 | M | 10,000 | D | Jun 28, 2008 | Jun 28, 2017 | Common Stock | 10,000 | 0 | D |
| Stock Option (Right to Buy)F7,F6 | $7.39 | Jun 14, 2016 | M | 10,000 | D | Mar 31, 2014 | Jan 31, 2024 | Common Stock | 10,000 | 15,000 | D |
| Stock Option (Right to Buy)F7 | $7.39 | Jun 15, 2016 | M | 15,000 | D | Mar 31, 2014 | Jan 31, 2024 | Common Stock | 15,000 | 0 | D |
| Stock Option (Right to Buy)F8 | $6.45 | Jun 15, 2016 | M | 25,000 | D | Mar 31, 2015 | Jan 31, 2025 | Common Stock | 25,000 | 0 | D |
| Stock Option (Right to Buy)F9 | $4.91 | Jun 15, 2016 | M | 6,250 | D | Mar 31, 2016 | Feb 1, 2026 | Common Stock | 6,250 | 18,750 | D |
Explanation of responses
- F1The shares were acquired and sold upon exercise of stock options that would have expired on 10/21/2016 (three months following termination of service as a director), in which event the reporting person would have lost the right to acquire the shares underlying the options.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.20 to $8.21, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.13 to $8.155, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote.
- F4The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.23 to $8.265, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote.
- F5The stock options were granted on 06/28/2007 and vested in three annual installments commencing on 06/28/2008.
- F6The stock options would have expired on 10/21/2016 (three months following termination of service as a director), in which event the holder would have lost the right to acquire the shares underlying the options.
- F7The stock options were granted on 01/31/2014 and vested as to one-fourth of the options in quarterly installments commencing on March 31, 2014.
- F8The stock options were granted on 01/31/2015 and vested as to one-fourth of the options in quarterly installments commencing on March 31, 2015.
- F9The stock options were granted on 02/01/2016 and vest as to one-fourth of the options in quarterly installments commencing on March 31, 2016.